This assessment took place on 18 February 2026. This was a planned comprehensive assessment completed under the single assessment framework whichis based on a set of quality statements. They are arranged under topic areas and describe what good care looks like. Esk Moors Caring is a domiciliary care service supporting adults with a range of needs in their own homes, including older and younger people, people with dementia and those with physical disabilities. At the time of the inspection 17 people were receiving a service. People continued to receive good quality, person centred care. They told us staff were kind, respectful and attentive, and that carers understood their routines, preferences and what mattered to them. Staff promoted independence and choice, adapting support sensitively when people’s needs changed. Risks were assessed and managed well. Staff recognised individual vulnerabilities, responded appropriately to concerns and worked with people to help them stay safe. Systems for safeguarding, managing medicines and preventing infection were applied consistently. Care was delivered in line with best practice, and assessments were thorough and regularly reviewed. Staff communicated well with each other and external professionals, helping ensure continuity and joined up care. The service was well led, with a visible and supportive registered manager. Governance systems were effective, with regular audits, oversight of care documentation and a strong learning culture that supported ongoing improvement. Staff felt valued, listened to and confident to raise concerns. People and relatives were consistently positive about the service and the reliability of care provided. There were no breaches of regulation, and previous good practice had been sustained.
npm run etl:reports -- --location 1-3045579117.Esk Moors Caring Limited received a Good rating across all five key questions at its first CQC inspection in October 2017, demonstrating strong safeguarding, person-centred care, and an engaged registered manager. Minor gaps were noted in topical medication recording on MARs, the absence of response timescales in the complaints policy, and inconsistent documentation of quality assurance actions.